A Novel Fluorescent Toxin to Detect and Investigate Kv1.3 Channel Up-regulation in Chronically Activated T Lymphocytes
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
T lymphocytes with unusually high expression of the voltage-gated Kv1.3 channel (Kv1.3(high) cells) have been implicated in the pathogenesis of experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis. We have developed a fluoresceinated analog of ShK (ShK-F6CA), the most potent known inhibitor of Kv1.3, for detection of Kv1.3(high) cells by flow cytometry. ShK-F6CA blocked Kv1.3 at picomolar concentrations with a Hill coefficient of 1 and exhibited >80-fold specificity for Kv1.3 over Kv1.1 and other K(V) channels. In flow cytometry experiments, ShK-F6CA specifically stained Kv1.3-expressing cells with a detection limit of approximately 600 channels per cell. Rat and human T cells that had been repeatedly stimulated 7-10 times with antigen were readily distinguished on the basis of their high levels of Kv1.3 channels (>600 channels/cell) and ShK-F6CA staining from resting T cells or cells that had undergone 1-3 rounds of activation. Functional Kv1.3 expression levels increased substantially in a myelin-specific rat T cell line following myelin antigen stimulation, peaking at 15-20 h and then declining to baseline over the next 7 days, in parallel with the acquisition and loss of encephalitogenicity. Both calcium- and protein kinase C-dependent pathways were required for the antigen-induced Kv1.3 up-regulation. ShK-F6CA might be useful for rapid and quantitative detection of Kv1.3(high) expressing cells in normal and diseased tissues, and to visualize the distribution of functional channels in intact cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A validated fluorescein-conjugated ShK analog (ShK-F6CA) was used to detect functional cell surface Kv1.3 channels in microglia (Peptides International (Louisville, Kentucky) [26, 27].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [27]
In the citing paper
“we used a validated flow-cytometric approach [26, 27] in which cells are incubated with a fluorescent Kv1.3 blocker ShK-F6CA which selectively binds to functional Kv1.3 channels.”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [27]
Citations
Cites
Calcium signaling mechanisms in T lymphocytes.
Lewis, R. S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.497 · Cited by 860
Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., Karmilowicz, M. J., Auperin, D. D., & Chandy, K. G. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10594-4 · Cited by 777
Self-citationVoltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
DeCoursey, T. E., Chandy, K. G., Gupta, S., & Cahalan, M. D. (1984) · Nature · doi:10.1038/307465a0 · Cited by 744
Self-citationA cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis
KING, D. S., FIELDS, C. G., & FIELDS, G. B. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00976.x · Cited by 725
Wulff, H., Miller, M. J., Hänsel, W., Grissmer, S., Cahalan, M. D., & Chandy, K. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8151 · Cited by 604
Self-citationMultiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593
Up-regulation of the IKCa1 Potassium Channel during T-cell Activation
Ghanshani, S., Wulff, H., Miller, M. J., Rohm, H., Neben, A., Gutman, G. A., Cahalan, M. D., & Chandy, K. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003941200 · Cited by 406
Self-citationProtein Kinase Cθ in T Cell Activation
Isakov, N., & Altman, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064807 · Cited by 376
Voltage-gated potassium channels are required for human T lymphocyte activation.
Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., McLaughlin, C., & Gupta, S. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.369 · Cited by 338
Self-citationBeeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Self-citation
Research works printed but not linked: 2
- Strauss, 1998, Receptors Channels, 6, 73
- Grissmer, 1994, Mol. Pharmacol., 45, 1227
Cited by
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
“3 channels have been proposed to be crucial in the pathogenesis of multiple sclerosis and other autoimmune disease”
BackgroundThe functional network of ion channels in T lymphocytes
Cahalan, M. D., & Chandy, K. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00816.x · Cited by 599
“3 have been engineered (20, 40, 41), including a fluorescent toxin analog that can be used in flow cytometry (42).”
BackgroundSelf-citationRangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
“3 channels in microglia (Peptides International (Louisville, Kentucky) [26, 27].”
BackgroundMethodSelf-citationK+ channels as targets for specific immunomodulation
George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.010 · Cited by 427
“Attachment of fluorescein-6-carboxylic acid (F6CA) through a nine-atom hydrophilic linker to Arg1 of ShK (Figure 3a) yielded a potent and specific inhibitor of Kv1.3 channels (Table 1) that detected, using flow cytometry, high levels of Kv1.3 channels (Kv1.3high )i n chronically activated T cells [ 40 ].”
BackgroundMethodResultInfluentialSelf-citationThe voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
“3high IKCa1low pattern is found in chronically activated rat memory T cells (18, 19), we suspected that the myelin antigen–activated patient cells with enhanced Kv1.”
BackgroundInfluentialSelf-citationBeeton, C., Pennington, M. W., Wulff, H., Singh, S., Nugent, D., Crossley, G., Khaytin, I., Calabresi, P. A., Chen, C.-Y., Gutman, G. A., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008193 · Cited by 249
“First, PAS cells were stained with ShK-F6CA (10 nM; Bachem Bioscience Inc.), a fluorophore-tagged ShK analog, and analyzed by flow cytometry as described previously (Beeton et al., 2003).”
BackgroundMethodInfluentialSelf-citationFeske, S., Prakriya, M., Rao, A., & Lewis, R. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050687 · Cited by 240
“Flow cytometric measurements of surface binding of fluorescently labeled ShK-F6CA (42) confirmed equivalent surface expression of Kv1.”
ResultK+Channel Modulators for the Treatment of Neurological Disorders and Autoimmune Diseases
Wulff, H., & Zhorov, B. S. (2008) · Chemical Reviews · doi:10.1021/cr078234p · Cited by 224
Self-citationWulff, H., Knaus, H.-G., Pennington, M., & Chandy, K. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.776 · Cited by 194
“ShK-F6CA, an analog of ShK (37) that exhibits 80-fold selectivity for Kv1.”
BackgroundSelf-citationKv1.3-Blocking 5-Phenylalkoxypsoralens: A New Class of Immunomodulators
Vennekamp, J., Wulff, H., Beeton, C., Calabresi, P. A., Grissmer, S., Hänsel, W., & Chandy, K. G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1364 · Cited by 136
“They were maintained in culture by alternating rounds of antigeninduced activation and expansion in interleukin-2–containing medium (Beeton et al., 2001b, 2003).”
BackgroundSelf-citationA stochastic view of lymphocyte motility and trafficking within the lymph node
Wei, S. H., Parker, I., Miller, M. J., & Cahalan, M. D. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00076.x · Cited by 117
Self-citationIon channels and lymphocyte activation
Panyi, G., Varga, Z., & Gáspár, R. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.020 · Cited by 126
Tight junctions potentiate the insulative properties of small CNS myelinated axons
Devaux, J., & Gow, A. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200808034 · Cited by 107
“6-FAM-SHK labeling Freshly dissected optic nerves (unfi xed) were incubated for 1 h into oxygenated ACSF maintained at 35 ° C and containing 500 nM 6-FAMSHK (Bachem; Beeton et al., 2003 ).”
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903018957 · Cited by 99
“The addition of an N-terminal hydrophilic extension with a negatively charged fluorescein moiety (ShK-F6CA) or L-phosophotyrosine (ShK-170) resulted in inhibitors with greater than 100-fold specificity over closely related channels [28,99,100].”
BackgroundSelf-citationAnalogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases
Beeton, C., W. Pennington, M., & S. Norton, R. (2011) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152811797200641 · Cited by 98
“ShK-F6CA blocked Kv1.”
BackgroundMethodSelf-citationK+ Channel Blockers: Novel Tools to Inhibit T Cell Activation Leading to Specific Immunosuppression
Panyi, G., Possani, L. D., Vega, R. C., Gáspár, R., & Varga, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585120 · Cited by 103
Hu, L., Pennington, M., Jiang, Q., Whartenby, K. A., & Calabresi, P. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4563 · Cited by 92
“3-specific pharmacological blockers improved the course of disease in experimental autoimmune encephalomyelitis if either the myelin basic protein (MBP)-reactive T cells used to induce disease were treated in vitro or if the rats themselves were treated in vivo after T cell transfer (8, 9).”
BackgroundSelf-citationDiversity of Potassium Channel Ligands: Focus on Scorpion Toxins
Kuzmenkov, A. I., Grishin, E. V., & Vassilevski, A. A. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915130118 · Cited by 89
“fluorescence activated cell sorting [82] and single molecule fluorescence microscopy [83]), that have largely replaced radioligand binding assay [83].”
MethodThe K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
Bradding, P. H., & Wulff, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00362.x · Cited by 77
“1 channels per cell (Beeton et al., 2003; Wulff et al., 2003).”
Self-citationPotassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23
Rangaraju, S., Khoo, K. K., Feng, Z., Crossley, G., Nugent, D., Khaytin, I., Chi, V., Pham, C., Calabresi, P. A., Pennington, M. W., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071266 · Cited by 77
Self-citationRangaraju, S., Raza, S. A., Pennati, A., Deng, Q., Dammer, E. B., Duong, D., Pennington, M. W., Tansey, M. G., Lah, J. J., Betarbet, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0906-6 · Cited by 75
Self-citationTanner, M. R., Tajhya, R. B., Huq, R., Gehrmann, E. J., Rodarte, K. E., Atik, M., Norton, R. S., Pennington, M. W., & Beeton, C. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.014 · Cited by 83
Self-citationVenom therapy in multiple sclerosis
Mirshafiey, A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.002 · Cited by 69
Rashid, M. H., Heinzelmann, G., Huq, R., Tajhya, R. B., Chang, S. C., Chhabra, S., Pennington, M. W., Beeton, C., Norton, R. S., & Kuyucak, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078712 · Cited by 72
“Several analogs with the desired selectivity have been developed, e.g. ShK-Dap22 [6], ShK-F6CA [8], ShK-186 [9], and ShK-192 [10], but all of them contain non-natural amino acids and/or adducts, and, in the case of ShK-186, the phosphorylated Tyr residue is susceptible to hydrolysis.”
BackgroundSelf-citationBlocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
Koshy, S., Huq, R., Tanner, M. R., Atik, M. A., Porter, P. C., Khan, F. S., Pennington, M. W., Hanania, N. A., Corry, D. B., & Beeton, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517037 · Cited by 66
“01 when comparing mean fluorescence intensity of T cells from asthma-induced sputum with T cells from the other three samples), suggesting a number of channels below the 600-channel detection threshold described for ShK-F6CA (11, 24).”
BackgroundMethodInfluentialSelf-citationVariability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1
Kuzmenkov, A. I., Vassilevski, A. A., Kudryashova, K. S., Nekrasova, O. V., Peigneur, S., Tytgat, J., Feofanov, A. V., Kirpichnikov, M. P., & Grishin, E. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.637611 · Cited by 82
“Kv1 channels were studied using flow cytometry (60), single molecule fluorescent microscopy (61), and the analysis of membrane potential changes using fluorescent dyes and fluorescence readers (62).”
MethodNicolaou, S. A., Szigligeti, P., Neumeier, L., Lee, S. M., Duncan, H. J., Kant, S. K., Mongey, A. B., Filipovich, A. H., & Conforti, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.346 · Cited by 63
“Similar capacitance values have been reported for quiescent and preactivated human T cells (39).”
BackgroundBeeton, C., Smith, B. J., Sabo, J. K., Crossley, G., Nugent, D., Khaytin, I., Chi, V., Chandy, K. G., Pennington, M. W., & Norton, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706008200 · Cited by 56
Self-citationMurray, J. K., Qian, Y., Liu, B., Elliott, R., Aral, J., Park, C., Zhang, X., Stenkilsson, M., Salyers, K. L., Rose, M. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00495 · Cited by 51
Varga, Z., Hajdú, P., & Panyi, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.12.015 · Cited by 50
Li, Z., Liu, W., Han, S. H., Peng, B., Yin, J., Wu, Y., He, X., & Li, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379594 · Cited by 51
“ShK-F6CA (9), OSK1 (10), margatoxin (11), etc.”
Sea Anemone Toxins Affecting Potassium Channels
Diochot, S., & Lazdunski, M. (2009) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-87895-7_4 · Cited by 54
Gilquin, B., Braud, S., Eriksson, M. A. L., Roux, B., Bailey, T. D., Priest, B. T., García, M. L., Ménèz, A., & Gasparini, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413626200 · Cited by 48
Ramesha, S., Rayaprolu, S., Bowen, C. A., Giver, C. R., Bitarafan, S., Nguyen, H. M., Gao, T., Chen, M. J., Nwabueze, N. V., Dammer, E. B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013545118 · Cited by 52
“Discussion Selective inhibition of proinflammatory CNS-MP responses has emerged as a promising therapeutic approach for disease modification in neurodegenerative diseases, ischemic stroke, and neuroinflammatory disorders (25, 29, 30, 33, 53, 54).”
BackgroundMethodInfluentialSelf-citationDifferences in ion channel phenotype and function between humans and animal models
Beeton, C. (2017) · Frontiers in bioscience · doi:10.2741/4581 · Cited by 50
Self-citationPennington, M. W., Rashid, M. H., Tajhya, R. B., Beeton, C., Kuyucak, S., & Norton, R. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.038 · Cited by 41
“More selective analogues have been created by the incorporation of non-natural amino acids or adducts, including ShK-Dap22, in which Lys22 was replaced by the positively-charged, non-natural residue 1,3-diaminopropionic acid (Dap) [12], ShK-F6CA, a fluorescein-labelled analogue of ShK [17], and analogues with either p…”
BackgroundSelf-citationMouhat, S., Teodorescu, G., Homerick, D., Visan, V., Wulff, H., Wu, Y., Grissmer, S., Darbon, H., WAARD, M. M. D., & Sabatier, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017210 · Cited by 38
Self-citationJin, L., Boyd, B. J., White, P. J., Pennington, M. W., Norton, R. S., & Nicolazzo, J. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.001 · Cited by 34
Self-citationKudryashova, K. S., Nekrasova, O. V., Kuzmenkov, A. I., Vassilevski, A. A., Ignatova, A. A., Korolkova, Y. V., Grishin, E. V., Kirpichnikov, M. P., & Feofanov, A. V. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6655-6 · Cited by 34
“Reports include fluorescence flow cytometry [27], single-molecule fluorescence microscopy [28], and fluorometric imaging plate reader (FLIPR) membrane potential assay [29].”
MethodChang, S., Huq, R., Chhabra, S., Beeton, C., Pennington, M. W., Smith, B. J., & Norton, R. S. (2015) · FEBS Journal · doi:10.1111/febs.13294 · Cited by 34
Self-citationWang, Y., Zhu, D., Ortiz-Velez, L., Perry, J. L., Pennington, M. W., Hyser, J. M., Britton, R. A., & Beeton, C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211977120 · Cited by 32
Self-citationOdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae
Abdel–Mottaleb, Y., Vandendriessche, T., Clynen, E., Landuyt, B., Jalali, A., Vatanpour, H., Schoofs, L., & Tytgat, J. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.03.027 · Cited by 31
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M. W., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316921 · Cited by 30
Self-citationNguyen, H. M., Galea, C. A., Schmunk, G., Smith, B. J., Edwards, R. A., Norton, R. S., & Chandy, K. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421495 · Cited by 29
“Electrophysiology—The whole-cell patch clamp technique (11) was used to characterize the current amplitude of COS-7 cells transiently expressingKV channels as described previously (12, 13), in the presence of different MMP23 constructs.”
MethodSelf-citationMiddleton, R. E., Sánchez, M., Linde, A.-R., Bugianesi, R. M., Dai, G., Felix, J. P., Koprak, S., Staruch, M. J., Bruguera, M., Cox, R., et al. (2003) · Biochemistry · doi:10.1021/bi035209e · Cited by 29
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity
Liu, J., Xu, P., Collins, C., Liu, H., Zhang, J., Keblesh, J. P., & Xiong, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064904 · Cited by 28
“3 channel expression, which changes dramatically as T cells differentiate from naı̈ve to memory states or transition from resting to activation [54,55,56].”
BackgroundProximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in Microglia
Bowen, C. A., Nguyen, H. M., Lin, Y. Q., Bagchi, P., Natu, A., Espinosa‐García, C., Werner, E., Kumari, R., Brandelli, A. D., Kumar, P., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100809 · Cited by 25
Self-citationMatkó, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00198-6 · Cited by 25
Wang, J., & Xiang, M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1236 · Cited by 25
Liao, Q., Gong, G., Siu, S. W. I., Wong, C. T. T., Yu, H., Tse, Y. C., Rádis‐Baptista, G., & Lee, S. M. (2018) · Toxins · doi:10.3390/toxins10060238 · Cited by 23
“ShK-F6CA was a fluorescein-labeled analog of ShK [6].”
BackgroundGao, T., Raza, S. A., Ramesha, S., Nwabueze, N. V., Tomkins, A. J., Cheng, L., Xiao, H., Yepes, M., & Rangaraju, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1510-8 · Cited by 25
Bingham, J., Bian, S., Tan, Z., Takacs, Z., & Moczydlowski, E. G. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060002u · Cited by 23
High-Throughput Profiling of Ion Channel Activity in Primary Human Lymphocytes
Estes, D. J., Memarsadeghi, S., Lundy, S. K., Martí, F., Mikol, D. D., Fox, D. A., & Mayer, M. (2008) · Analytical Chemistry · doi:10.1021/ac800164v · Cited by 22
Kuzmenkov, A. I., & Vassilevski, A. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.10.050 · Cited by 22
Chang, S. C., Galea, C. A., Leung, E. W. W., Tajhya, R. B., Beeton, C., Pennington, M. W., & Norton, R. S. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.05.017 · Cited by 22
“, 1998); ShK-F6CA, a fluorescein-labelled analogue of ShK (Beeton et al., 2003); and analogues with either phospho-Tyr (ShK-186) or phosphono-Phe (ShK-192) attached via a hydrophilic linker (i.”
Self-citationBednenko, J., Harriman, R., Mariën, L., Nguyen, H. M., Agrawal, A., Papoyan, A., Bisharyan, Y., Cardarelli, J., Cassidy-Hanley, D., Clark, T., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1445451 · Cited by 21
“4 nM (n=3), approximately 200-fold lower than the IC50 (52 pM) reported for FAM-ShK using patch clamp electrophysiology (27).”
BackgroundSelf-citationPethő, Z., Tanner, M. R., Tajhya, R. B., Huq, R., Laragione, T., Panyi, G., Gulko, P. S., & Beeton, C. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1003-4 · Cited by 22
“1 and of CD44, podoplanin, cadherin 11, and intracellular matrix metalloproteinase (MMP)-2 was performed as previously described [12, 41, 43] using antibodies listed in Table 3.”
MethodSelf-citationPotassium Channels in T Lymphocytes: Therapeutic Targets for Autoimmune Disorders?
Vianna‐Jorge, R., & Suarez‐Kurtz, G. (2004) · BioDrugs · doi:10.2165/00063030-200418050-00005 · Cited by 24
Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
Markakis, I. A., Charitakis, I., Beeton, C., Galani, M., Repousi, E., Aggeloglou, S., Sfikakis, P. P., Pennington, M. W., Chandy, K. G., & Poulopoulou, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.714841 · Cited by 18
Self-citationPotassium currents inhibition by gambierol analogs prevents human T lymphocyte activation
Rubiolo, J. A., Vale, C., Martín, V., Fuwa, H., Sasaki, M., & Botana, L. M. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1299-2 · Cited by 21
A Cell-Based Rb + -Flux Assay of the Kv1.3 Potassium Channel
Gill, S. S., Gill, R. K., Wicks, D., & Liang, D. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.004 · Cited by 17
“11 However, the assay suffers from limitations due to fluorescence artifacts.”
Matsushita, Y., Ohya, S., Suzuki, Y., Itoda, H., Kimura, T., Yamamura, H., & Imaizumi, Y. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00668.2008 · Cited by 14
“PIP(2) and proteins: interactions, organization, and information flow.”
BackgroundInfluentialBergfeld, A., Dasari, P., Werner, S., Hughes, T. R., Song, W., Hortschansky, P., Brakhage, A. A., Hünig, T., Zipfel, P. F., & Beyersdorf, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00844 · Cited by 15
“3 μg/ml; Bachem AG, Bubendorf, Switzerland) was incubated together with mAb against cell surface proteins for 30 min at room temperature (Beeton et al., 2003).”
MethodInfluentialN-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site
Nekrasova, O. V., Primak, A. L., Ignatova, A. A., Novoseletsky, V. N., Geraskina, O. V., Kudryashova, K. S., Yakimov, S. A., Kirpichnikov, M. P., Arseniev, A. S., & Feofanov, A. V. (2020) · Toxins · doi:10.3390/toxins12120802 · Cited by 14
Orlov, N. A., Ignatova, A. A., Kryukova, E. V., Yakimov, S. A., Kirpichnikov, M. P., Nekrasova, O. V., & Feofanov, A. V. (2022) · Toxins · doi:10.3390/toxins14120858 · Cited by 13
Potentiometric platform for the quantification of cellular potassium efflux
Generelli, S., Jacquemart, R., de Rooij, N. F., Jolicœur, M., Koudelka‐Hep, M., & Guenat, O. T. (2008) · Lab on a Chip · doi:10.1039/b801042k · Cited by 14
In Vitro Evaluation of Functional Interaction of Integrin αvβ3 and Matrix Metalloprotease-2
Vartak, D. G., Lee, B.-S., & Gemeinhart, R. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900152t · Cited by 17
Ueyama, A., Imura, K., Kasai-Yamamoto, E., Tai, N., Nagira, M., Shichijo, M., & Yasui, K. (2013) · Clinical and Experimental Dermatology · doi:10.1111/ced.12097 · Cited by 11
Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury
Fortune, R. D., Grill, R. J., Beeton, C., Tanner, M. R., Huq, R., & Loose, D. S. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4641 · Cited by 10
“For each sample, doublet discrimination was performed on 30,000 acquired events.(39) Metabolomic Analysis: After collection at each of the time points listed above, the right testes were homogenized under liquid nitrogen.”
Self-citationGFP–Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers
Denisova, K. R., Orlov, N. A., Yakimov, S. A., Kryukova, E. A., Dolgikh, D. A., Kirpichnikov, M. P., Feofanov, A. V., & Nekrasova, O. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031724 · Cited by 10
“3 overexpressing T lymphocytes by flow cytometry [16], and tetramethylrhodamine-labeled agitoxin 2 (AgTx2), used as a fluorescent probe to search for and study peptide ligands of Kv1 channels [17].”
BackgroundShK toxin: history, structure and therapeutic applications for autoimmune diseases
Chang, S. C., Bajaj, S., & Chandy, K. G. (2018) · WikiJournal of Science · doi:10.15347/wjs/2018.003 · Cited by 8
“1.([27]) The enhanced specificity of ShK-F6CA might be explained by differences in charge: F6CA is negatively charged; tetramethylrhodamine is positively charged; and biotin is neutral.”
BackgroundInfluentialSelf-citationToxin binding to chimeric K+ channels immobilised on a solid nitrocellulose support
Legros, C., Martin‐Eauclaire, M., Pongs, O., & Bougis, P. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.156 · Cited by 8
“Also the affinity for Kv1.3 of the fluorescent conjugates of the sea anemone toxin ShK were only one fifth of that of the unmodified toxin [ 23 ].”
BackgroundSelective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo
Angi, B., Varanita, T., Puthenparampil, M., Scattolini, V., Donadon, M., Tavakoli, M., Favero, M., Boustani, M. E., Soddemann, M., Biasutto, L., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00307-2 · Cited by 10
A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel KV1.3
Wai, D. C. C., Naseem, M. U., Mocsár, G., Reddiar, S. B., Pan, Y., Csóti, A., Hajdú, P., Nowell, C. J., Nicolazzo, J. A., Panyi, G., et al. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00436 · Cited by 9
Xu, M., Xu, Y., Shen, Y., Lou, C., Zheng, M., & Kang, J. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.05.010 · Cited by 7
Sebestyén, V., Nagy, É., Mocsár, G., Volkó, J., Szilágyi, O., Kenesei, Á., Panyi, G., Tóth, K., Hajdú, P., & Vámosi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063313 · Cited by 6
Chow, C. Y., & King, G. F. (2024) · Toxins · doi:10.3390/toxins16070307 · Cited by 7
Precious Natural Peptides from Spider Venoms: New Tools for Studying Potassium Channels
Diochot, S. (2005) · Toxin Reviews · doi:10.1080/07313830500237059 · Cited by 5
“(Beeton et al., 2001; Beeton et al., 2003; Mourre et al., 1997).”
Kady, M. R., Elston, R. N., Snyder, L. J., Fleischman, J. D., Brandt, M. J., Zhu, D., Britton, R. A., & Beeton, C. (2025) · Microbial Cell Factories · doi:10.1186/s12934-025-02800-2 · Cited by 5
“To detect IbTX in serum based on competitive binding to HEK-K Ca 1.1 [35], we used a biotinylated analog of IbTX [32].”
InfluentialSelf-citationComputational Insights of the Interaction among Sea Anemones Neurotoxins and Kv1.3 Channel
Sabogal, A., Barreto, G. E., Ramírez, D., González-Mendoza, J., Barreto, L. V., Morales, L., & González, J. (2014) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s13403 · Cited by 4
“The novelty presented here relies on the pattern of interaction expressed as X(5)–[FT]– [KI]–X(3)–R–X(4)–Q–X(4)–M–K–Y–Q–K–[SY]–F that may serve as an input to generate a stable bonding between the Kv1.”
InfluentialIntermediate conductance, Ca2+-activated K+ channels: a novel target for chronic renal diseases
Bertuccio, C. A., & Devor, D. C. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1339-6 · Cited by 4
Sudandiradoss, C., & Sethumadhavan, R. (2009) · The Open Structural Biology Journal · doi:10.2174/1874199100903020075 · Cited by 1
“Researchers at the University of California have recently reported [53] that myelin-reactive encephalitogenic rat T cells expressed unusually high numbers of Kv1.”
BackgroundSudandiradoss, C., & Sethumadhavan, R. (2009) · The Open Structural Biology Journal · doi:10.2174/1874199100903010075 · Cited by 1
Gago-Martínez, A., & Gerssen, A. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-349-8 · Cited by 2
of the Voltage-Gated Potassium Channel Characterization of the Functional Properties
Calabresi, P. A., Hu, L., Pennington, M. W., Jiang, Q., & Katharine, A. (2017)
Self-citationTargeting prokaryotic ion channel by a chimera of fluorescent protein and artificial peptide toxin
Iunusova, V. A., Orlov, N. A., Nekrasova, O. V., Feofanov, A. V., Vassilevski, A. A., & Kuzmenkov, A. I. (2025) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2025.184458
A Fluorescent Protein-Tagged Scorpion Toxin with Picomolar Affinity for the Kv1.3 K + Channel
Borrego, J., Naseem, M. U., Olaimi, A. S. A., Korpos, É., Szöőr, Á., Batta, G., & Panyi, G. (2026) · ACS Omega · doi:10.1021/acsomega.5c10479 · Cited by 1
Synthèse d’outils pour le marquage métabolique des glycanes.
Carlier, M. (2019) · theses.fr (ABES) · doi:10.70675/f7397fe1z18bfz41d8za18dz8ac2775d94ef · Cited by 1
Metadata
- Authors
- Beeton, C., Wulff, H., Singh, S., Botsko, S., Crossley, G., Gutman, G. A., Cahalan, M. D., Pennington, M., & Chandy, K. G.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Chandy, K. George
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9928-9937
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022760884
- Cited by
- 90
- References
- 47
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh059222-04)
- National Institute of Mental Health (MH59222)
- National Institute of Neurological Disorders and Stroke (NS-14609)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- Kv1.3 potassium channel, T cell activation, experimental autoimmune encephalomyelitis, multiple sclerosis, myelin-specific T cells, encephalitogenicity, protein kinase C, calcium signaling
- MeSH terms
- Amino Acids, Animals, Antigens, Biotin, Calcium, Cell Line, Cell Nucleus, Cnidarian Venoms, Dose-Response Relationship, Drug, Electrophysiology, Flow Cytometry, Fluoresceins, Fluorescent Dyes, Guinea Pigs, Humans, Kinetics, Lymphocytes, Models, Molecular, Magnetic Resonance Spectroscopy, Peptides, Protein Kinase C, Rats, Inbred Lew, T-Lymphocytes, Time Factors, Tissue Distribution, Potassium Channels, Up-Regulation, Potassium Channels, Voltage-Gated, Mice, Rats, Kv1.3 Potassium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.